In HNSCC, ANO1-induced cancer cell proliferation and tumor growth are coupled with activation of extracellular-regulated kinases 1/2 (ERK1/2), and inhibition of ERK1/2 effectively reduces ANO1-driven cell proliferation (143). The gene discussed is ANO1; the disease is neoplasm.